These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 26787701)

  • 21. Inhibition of subgenomic hepatitis C virus RNA in Huh-7 cells: ribavirin induces mutagenesis in HCV RNA.
    Kanda T; Yokosuka O; Imazeki F; Tanaka M; Shino Y; Shimada H; Tomonaga T; Nomura F; Nagao K; Ochiai T; Saisho H
    J Viral Hepat; 2004 Nov; 11(6):479-87. PubMed ID: 15500548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross Talk between Nucleotide Synthesis Pathways with Cellular Immunity in Constraining Hepatitis E Virus Replication.
    Wang Y; Wang W; Xu L; Zhou X; Shokrollahi E; Felczak K; van der Laan LJ; Pankiewicz KW; Sprengers D; Raat NJ; Metselaar HJ; Peppelenbosch MP; Pan Q
    Antimicrob Agents Chemother; 2016 May; 60(5):2834-48. PubMed ID: 26926637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zinc Salts Block Hepatitis E Virus Replication by Inhibiting the Activity of Viral RNA-Dependent RNA Polymerase.
    Kaushik N; Subramani C; Anang S; Muthumohan R; Shalimar ; Nayak B; Ranjith-Kumar CT; Surjit M
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28814517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C19orf66 is an interferon-induced inhibitor of HCV replication that restricts formation of the viral replication organelle.
    Kinast V; Plociennikowska A; Anggakusuma ; Bracht T; Todt D; Brown RJP; Boldanova T; Zhang Y; Brüggemann Y; Friesland M; Engelmann M; Vieyres G; Broering R; Vondran FWR; Heim MH; Sitek B; Bartenschlager R; Pietschmann T; Steinmann E
    J Hepatol; 2020 Sep; 73(3):549-558. PubMed ID: 32294532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening of novel drugs for inhibiting hepatitis E virus replication.
    Nishiyama T; Kobayashi T; Jirintai S; Kii I; Nagashima S; Prathiwi Primadharsini P; Nishizawa T; Okamoto H
    J Virol Methods; 2019 Aug; 270():1-11. PubMed ID: 31004661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C virus kinetics by administration of pegylated interferon-α in human and chimeric mice carrying human hepatocytes with variants of the IL28B gene.
    Watanabe T; Sugauchi F; Tanaka Y; Matsuura K; Yatsuhashi H; Murakami S; Iijima S; Iio E; Sugiyama M; Shimada T; Kakuni M; Kohara M; Mizokami M
    Gut; 2013 Sep; 62(9):1340-6. PubMed ID: 23135762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon-alpha treatment rapidly clears Hepatitis E virus infection in humanized mice.
    van de Garde MDB; Pas SD; van Oord GW; Gama L; Choi Y; de Man RA; Boonstra A; Vanwolleghem T
    Sci Rep; 2017 Aug; 7(1):8267. PubMed ID: 28811492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative analysis of anti-hepatitis C virus activity and gene expression mediated by alpha, beta, and gamma interferons.
    Cheney IW; Lai VC; Zhong W; Brodhag T; Dempsey S; Lim C; Hong Z; Lau JY; Tam RC
    J Virol; 2002 Nov; 76(21):11148-54. PubMed ID: 12368359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiviral action of interferon-alpha against hepatitis C virus replicon and its modulation by interferon-gamma and interleukin-8.
    Jia Y; Wei L; Jiang D; Wang J; Cong X; Fei R
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1278-85. PubMed ID: 17565587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic inhibition of intracellular hepatitis C virus replication by combination of ribavirin and interferon- alpha.
    Tanabe Y; Sakamoto N; Enomoto N; Kurosaki M; Ueda E; Maekawa S; Yamashiro T; Nakagawa M; Chen CH; Kanazawa N; Kakinuma S; Watanabe M
    J Infect Dis; 2004 Apr; 189(7):1129-39. PubMed ID: 15031779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiviral candidates against the hepatitis E virus (HEV) and their combinations inhibit HEV growth in in vitro.
    Nishiyama T; Kobayashi T; Jirintai S; Nagashima S; Primadharsini PP; Nishizawa T; Okamoto H
    Antiviral Res; 2019 Oct; 170():104570. PubMed ID: 31362004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis E virus persists in the presence of a type III interferon response.
    Yin X; Li X; Ambardekar C; Hu Z; Lhomme S; Feng Z
    PLoS Pathog; 2017 May; 13(5):e1006417. PubMed ID: 28558073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Requirement of the eukaryotic translation initiation factor 4F complex in hepatitis E virus replication.
    Zhou X; Xu L; Wang Y; Wang W; Sprengers D; Metselaar HJ; Peppelenbosch MP; Pan Q
    Antiviral Res; 2015 Dec; 124():11-9. PubMed ID: 26526587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication.
    Metz P; Dazert E; Ruggieri A; Mazur J; Kaderali L; Kaul A; Zeuge U; Windisch MP; Trippler M; Lohmann V; Binder M; Frese M; Bartenschlager R
    Hepatology; 2012 Dec; 56(6):2082-93. PubMed ID: 22711689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.
    Nandakumar R; Finsterbusch K; Lipps C; Neumann B; Grashoff M; Nair S; Hochnadel I; Lienenklaus S; Wappler I; Steinmann E; Hauser H; Pietschmann T; Kröger A
    Gastroenterology; 2013 Dec; 145(6):1414-23.e1. PubMed ID: 23973921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The U-Rich Untranslated Region of the Hepatitis E Virus Induces Differential Type I and Type III Interferon Responses in a Host Cell-Dependent Manner.
    Sooryanarain H; Heffron CL; Meng XJ
    mBio; 2020 Jan; 11(1):. PubMed ID: 31937650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-28B (IFN-λ3) and IFN-α synergistically inhibit HCV replication.
    Shindo H; Maekawa S; Komase K; Miura M; Kadokura M; Sueki R; Komatsu N; Shindo K; Amemiya F; Nakayama Y; Inoue T; Sakamoto M; Yamashita A; Moriishi K; Enomoto N
    J Viral Hepat; 2013 Apr; 20(4):281-9. PubMed ID: 23490373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of interferon-α signaling by hepatitis E virus.
    Dong C; Zafrullah M; Mixson-Hayden T; Dai X; Liang J; Meng J; Kamili S
    Hepatology; 2012 May; 55(5):1324-32. PubMed ID: 22183878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics.
    Marcello T; Grakoui A; Barba-Spaeth G; Machlin ES; Kotenko SV; MacDonald MR; Rice CM
    Gastroenterology; 2006 Dec; 131(6):1887-98. PubMed ID: 17087946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.